Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Transactions / Two Ambulatory Infusion Centers

LUX Infusion Strengthens Northeast Presence with Acquisition of Two Ambulatory Infusion Centers

Add-on acquisitionannouncedadd-onannounced Sep 11, 2026Fact
What happened
Target
Two Ambulatory Infusion Centers
Platform
LUX Infusionadd-on basis: LUX Infusion is a portfolio company of Frazier Healthcare Partners.
Control
Control
Share acquired
unknown
Industry
healthcare / infusion
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • LUX InfusionPlatformconfirmed
    “LUX Infusion is a portfolio company of Frazier Healthcare Partners.”
  • Frazier Healthcare PartnersSponsorconfirmed
    “LUX Infusion is a portfolio company of Frazier Healthcare Partners.”
Side not stated
  • Ted KrammManagementconfirmed
    “"Our focus has always been on making complex infusion care easier to access and easier to navigate for patients, providers, and families," said Ted Kramm, Chief Executive Officer of LUX Infusion.”
  • Two Ambulatory Infusion CentersTargetconfirmed
    “LUX Infusion Strengthens Northeast Presence with Acquisition of Two Ambulatory Infusion Centers”
Evidence
“LUX Infusion Strengthens Northeast Presence with Acquisition of Two Ambulatory Infusion Centers”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
LUX Infusion Strengthens Northeast Presence with Acquisition of Two Ambulatory Infusion Ce | Private Equity Intelligence | DFX